
    
      PROTOCOL OUTLINE: This is a randomized, multicenter study Patients are randomized to receive
      the current formulation of cysteamine hydrochloride as drops in one eye and the new
      formulation of cysteamine hydrochloride as drops in the other eye.

      Patients receive the two formulations of cysteamine hydrochloride in their assigned eyes
      every hour during waking hours daily for 6 months (safety study) or for 1 year (efficacy
      study).
    
  